Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels
- PMID: 21646302
- PMCID: PMC3127556
- DOI: 10.4065/mcp.2011.0178
Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels
Abstract
Objective: To create a cohort for cost-effective genetic research, the Mayo Genome Consortia (MayoGC) has been assembled with participants from research studies across Mayo Clinic with high-throughput genetic data and electronic medical record (EMR) data for phenotype extraction.
Participants and methods: Eligible participants include those who gave general research consent in the contributing studies to share high-throughput genotyping data with other investigators. Herein, we describe the design of the MayoGC, including the current participating cohorts, expansion efforts, data processing, and study management and organization. A genome-wide association study to identify genetic variants associated with total bilirubin levels was conducted to test the genetic research capability of the MayoGC.
Results: Genome-wide significant results were observed on 2q37 (top single nucleotide polymorphism, rs4148325; P=5.0 × 10(-62)) and 12p12 (top single nucleotide polymorphism, rs4363657; P=5.1 × 10(-8)) corresponding to a gene cluster of uridine 5'-diphospho-glucuronosyltransferases (the UGT1A cluster) and solute carrier organic anion transporter family, member 1B1 (SLCO1B1), respectively.
Conclusion: Genome-wide association studies have identified genetic variants associated with numerous phenotypes but have been historically limited by inadequate sample size due to costly genotyping and phenotyping. Large consortia with harmonized genotype data have been assembled to attain sufficient statistical power, but phenotyping remains a rate-limiting factor in gene discovery research efforts. The EMR consists of an abundance of phenotype data that can be extracted in a relatively quick and systematic manner. The MayoGC provides a model of a unique collaborative effort in the environment of a common EMR for the investigation of genetic determinants of diseases.
Figures
Comment in
-
Genome-wide association studies go green: novel and cost-effective opportunities for identifying genetic associations.Mayo Clin Proc. 2011 Jul;86(7):597-9. doi: 10.4065/mcp.2011.0337. Mayo Clin Proc. 2011. PMID: 21719615 Free PMC article. No abstract available.
Similar articles
-
Genome-wide association meta-analysis for total serum bilirubin levels.Hum Mol Genet. 2009 Jul 15;18(14):2700-10. doi: 10.1093/hmg/ddp202. Epub 2009 May 4. Hum Mol Genet. 2009. PMID: 19414484 Free PMC article.
-
Genome-wide association studies go green: novel and cost-effective opportunities for identifying genetic associations.Mayo Clin Proc. 2011 Jul;86(7):597-9. doi: 10.4065/mcp.2011.0337. Mayo Clin Proc. 2011. PMID: 21719615 Free PMC article. No abstract available.
-
Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.Hum Mutat. 2009 Apr;30(4):609-15. doi: 10.1002/humu.20895. Hum Mutat. 2009. PMID: 19243019
-
[Research progress on the relationship between SLCO1B1 gene and neonatal jaundice].Zhongguo Dang Dai Er Ke Za Zhi. 2014 Nov;16(11):1183-7. Zhongguo Dang Dai Er Ke Za Zhi. 2014. PMID: 25406570 Review. Chinese.
-
Exploring the genetic architecture of neonatal hyperbilirubinemia.Semin Fetal Neonatal Med. 2010 Jun;15(3):169-75. doi: 10.1016/j.siny.2009.11.003. Epub 2009 Dec 21. Semin Fetal Neonatal Med. 2010. PMID: 20022574 Review.
Cited by
-
Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes.Nat Hum Behav. 2024 Jun;8(6):1177-1193. doi: 10.1038/s41562-024-01851-6. Epub 2024 Apr 17. Nat Hum Behav. 2024. PMID: 38632388 Free PMC article.
-
The genetic contribution to the comorbidity of depression and anxiety: a multi-site electronic health records study of almost 178 000 people.Psychol Med. 2023 Nov;53(15):7368-7374. doi: 10.1017/S0033291723000983. Epub 2023 May 5. Psychol Med. 2023. PMID: 38078748 Free PMC article.
-
The Michigan Genomics Initiative: A biobank linking genotypes and electronic clinical records in Michigan Medicine patients.Cell Genom. 2023 Jan 31;3(2):100257. doi: 10.1016/j.xgen.2023.100257. eCollection 2023 Feb 8. Cell Genom. 2023. PMID: 36819667 Free PMC article.
-
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services.Clin Transl Sci. 2023 Feb;16(2):292-304. doi: 10.1111/cts.13449. Epub 2022 Dec 12. Clin Transl Sci. 2023. PMID: 36510710 Free PMC article.
-
Serum bilirubin and kidney function: a Mendelian randomization study.Clin Kidney J. 2022 May 2;15(9):1755-1762. doi: 10.1093/ckj/sfac120. eCollection 2022 Sep. Clin Kidney J. 2022. PMID: 36003670 Free PMC article.
References
-
- Bathum L, Petersen HC, Rosholm JU, Hyltoft Petersen P, Vaupel J, Christensen K. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem. 2001;47(1):81-87 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources